EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Balancing Thrombosis and Bleeding: Antithrombotic Therapy in Cirrhosis-Related Thrombocytopenia

Sarah Taylor, Julie Wang iD, Hui Yin Lim iD, Glen Saward, Siddharth Sood iD

Journal of Clinical Medicine · 07.03.2026 · 15 (5) · 2036

DOI: 10.3390/jcm15052036 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.03.2026. Verfasst von Sarah Taylor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Northern Health, Epping, VIC 3076, Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of thrombocytopenia is common in cirrhosis. Further complex alterations in haemostasis also occur, resulting in a rebalanced state that predisposes patients to both thromboembolic and bleeding complications. Guidance on the management of thrombosis in patients with cirrhosis-related thrombocytopenia is limited and poses a common clinical dilemma. Anticoagulation in this population remains challenging due to altered drug pharmacokinetics, baseline abnormalities in conventional coagulation tests, limitations in laboratory monitoring, thrombocytopenia itself and concerns regarding bleeding risk. Low-molecular-weight heparin and vitamin K antagonists have traditionally been used; however, increasing data support the use of direct oral anticoagulants in patients with compensated cirrhosis. Management decisions should be individualised, incorporating liver disease severity, thrombotic burden, bleeding risk, and clinical factors such as portal hypertension. This review summarises current evidence on thromboembolic disease and antithrombotic therapy in cirrhosis-related thrombocytopenia. Further prospective studies are required to investigate key knowledge gaps, including optimal platelet thresholds for anticoagulation use and the role of functional coagulation testing in this population.

Schlagwörter

Stichwörter der Autor:innen

anticoagulationcirrhosisthrombocytopeniathrombosis

Autor:innen und Institutionen

  • Department of Gastroenterology, Northern Health, Epping, VIC 3076, Australia.
  • Northern Clinical Diagnostics & Thrombovascular Research (NECTAR), Northern Health, Epping, VIC 3076, Australia.
  • Department of Medicine, The University of Melbourne, Parkville, VIC 3010, Australia.
  • Department of Haematology, Northern Pathology Victoria, Northern Health, Epping, VIC 3076, Australia.
  • Australian Centre for Blood Diseases, Monash University, South Yarra, VIC 3181, Australia.
  • School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC 3001, Australia.

ORCID-Profile: Julie Wang, Hui Yin Lim, Siddharth Sood

Zitieren

APA

Taylor, S., Wang, J., Lim, H. Y., Saward, G., & Sood, S. (2026). Balancing Thrombosis and Bleeding: Antithrombotic Therapy in Cirrhosis-Related Thrombocytopenia. Journal of Clinical Medicine, 15(5), 2036. https://doi.org/10.3390/jcm15052036

Vancouver

Taylor S, Wang J, Lim HY, Saward G, Sood S. Balancing Thrombosis and Bleeding: Antithrombotic Therapy in Cirrhosis-Related Thrombocytopenia. Journal of Clinical Medicine. 2026;15(5):2036. doi:10.3390/jcm15052036

BibTeX
@article{Taylor2026,
  author = {Taylor, Sarah and Wang, Julie and Lim, Hui Yin and Saward, Glen and Sood, Siddharth},
  title = {Balancing Thrombosis and Bleeding: Antithrombotic Therapy in Cirrhosis-Related Thrombocytopenia},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {2036},
  doi = {10.3390/jcm15052036}
}
Kostenlos starten →